2026年10月16日星期五
M
Meridian Globe
ព័ត៌មានបន្ទាន់
[Comment] Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes— 柳叶刀 Lancet[Comment] Making every vial count: fractional dosing of yellow fever vaccine— 柳叶刀 Lancet[Comment] Shortening treatment to accelerate hepatitis C elimination— 柳叶刀 Lancet[Comment] Offline: In praise of astrologers, sorcerers, and magicians— 柳叶刀 Lancet[World Report] “You have to be willing to take risks”: the 2026 Nobel prizes— 柳叶刀 Lancet[World Report] Health in Brazil's election— 柳叶刀 Lancet[Perspectives] Shadows and interiority— 柳叶刀 Lancet[Perspectives] Beyond the battlefield: war and global health security— 柳叶刀 Lancet[Comment] Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes— 柳叶刀 Lancet[Comment] Making every vial count: fractional dosing of yellow fever vaccine— 柳叶刀 Lancet[Comment] Shortening treatment to accelerate hepatitis C elimination— 柳叶刀 Lancet[Comment] Offline: In praise of astrologers, sorcerers, and magicians— 柳叶刀 Lancet[World Report] “You have to be willing to take risks”: the 2026 Nobel prizes— 柳叶刀 Lancet[World Report] Health in Brazil's election— 柳叶刀 Lancet[Perspectives] Shadows and interiority— 柳叶刀 Lancet[Perspectives] Beyond the battlefield: war and global health security— 柳叶刀 Lancet

Variable clinical course of retinitis pigmentosa patients with RPE65 gene mutations

ប្រភព Nature 医学研究12 ម៉ោងមុន
Summary

Variable clinical course of retinitis pigmentosa patients with RPE65 gene mutations

យើងផ្តល់តែសន្ទស្សន៍ចំណងជើង និងសេចក្តីសង្ខេប។ ខ្លឹមសារពេញលេញ និងសិទ្ធិអ្នកនិពន្ធ ជាកម្មសិទ្ធិរបស់ប្រភពដើម — សូមចុចតំណដើមដើម្បីអាន។

បើកឯកសារដើម
ផ្នែកព័ត៌មាន
Health
តំបន់
Global
Language
English
Item ID
health-3bac96bd

Comments 0 comments

No comments yet. Be the first.

Variable clinical course of retinitis pigmentosa patients with RPE65 gene mutations · Meridian Globe